_id
69130c32ccc777a4e85d7ce4
Ticker
KVUE
Name
Kenvue Inc.
Exchange
NYSE
Address
1 Kenvue Way, Summit, NJ, United States, 07901
Country
USA
Sector
Consumer Defensive
Industry
Household & Personal Products
Currency
USD
Website
https://www.kenvue.com
Description
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Last Close
17.27
Volume
33292106
Current Price
16.83
Change
0.07
Last Updated
2026-01-04T16:16:03.739Z
Image
data:image/webp;base64,UklGRsQAAABXRUJQVlA4ILgAAABQBQCdASpAACsAPtFirVAoJaSipXgJmQAaCWMAzB2LpQMzIGwUv9XYwNrR6EmOQtu7cAAA/t+AAm7L3//kGP92X+knIAnkbGK6rKHBaINxZZ5A9YwlHtK8plKJd0cybRwwhym8dHl193DIK2RrGPvGj5yvZXA9rtwB6Varyqeegj542De2pB3njFKXWPmHTYES80KFI6WuHgXrrWmiZ9reQwo/ZsH2PA7zZT9WPKspK9T9GodAAAAA
Ipo Date
2023-05-04T00:00:00.000Z
Market Cap
33183469568
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7081742857142858
Sentiment Sources
35
Rating
3.4211
Target Price
19.3333
Strong Buy
3
Buy
2
Hold
14
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
3764000000
Cost Of Revenue
1538000000
Gross Profit
2226000000
Operating Expenses
1597000000
Operating Income
629000000
Interest Expense
93000000
Pretax Income
526000000
Net Income
398000000
Eps
0.20696827873114926
Dividends Per Share
-398000000
Shares Outstanding
1915904828
Income Tax Expense
128000000
EBITDA
760000000
Operating Margin
16.710945802337935
Total Other Income Expense Net
-103000000
Cash
1139000000
Short Term Investments
-
Receivables
2416000000
Inventories
1794000000
Total Current Assets
6032000000
Property Plant Equipment
2092000000
Total Assets
27248000000
Payables
2403000000
Short Term Debt
1951000000
Long Term Debt
7060000000
Total Liabilities
16614000000
Equity
10634000000
Bs_currency_symbol
USD
Depreciation
141000000
Change In Working Capital
58000000
Cash From Operations
294000000
Capital Expenditures
98000000
Cash From Investing
-104000000
Cash From Financing
-110000000
Net Change In Cash
1137900000
Cf_currency_symbol
USD
PE
23.0933
PB
3.0434540154222303
ROE
3.7427120556704905
ROA
1.4606576629477392
FCF
196000000
Fcf Percent
0.052072263549415514
Piotroski FScore
3
Health Score
43
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
5
Economic Moat Investing Score
6.8
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
6
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
3764000000
Quarters > 0 > income Statement > cost Of Revenue
1538000000
Quarters > 0 > income Statement > gross Profit
2226000000
Quarters > 0 > income Statement > operating Expenses
1597000000
Quarters > 0 > income Statement > operating Income
629000000
Quarters > 0 > income Statement > interest Expense
93000000
Quarters > 0 > income Statement > pretax Income
526000000
Quarters > 0 > income Statement > net Income
398000000
Quarters > 0 > income Statement > eps
0.20696827873114926
Quarters > 0 > income Statement > dividends Per Share
-398000000
Quarters > 0 > income Statement > shares Outstanding
1923000000
Quarters > 0 > income Statement > income Tax Expense
128000000
Quarters > 0 > income Statement > EBITDA
760000000
Quarters > 0 > income Statement > operating Margin
16.710945802337935
Quarters > 0 > income Statement > total Other Income Expense Net
-103000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1139000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2416000000
Quarters > 0 > balance Sheet > inventories
1794000000
Quarters > 0 > balance Sheet > total Current Assets
6032000000
Quarters > 0 > balance Sheet > property Plant Equipment
2092000000
Quarters > 0 > balance Sheet > total Assets
27248000000
Quarters > 0 > balance Sheet > payables
2403000000
Quarters > 0 > balance Sheet > short Term Debt
1951000000
Quarters > 0 > balance Sheet > long Term Debt
7060000000
Quarters > 0 > balance Sheet > total Liabilities
16614000000
Quarters > 0 > balance Sheet > equity
10634000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
398000000
Quarters > 0 > cash Flow > depreciation
141000000
Quarters > 0 > cash Flow > change In Working Capital
58000000
Quarters > 0 > cash Flow > cash From Operations
294000000
Quarters > 0 > cash Flow > capital Expenditures
98000000
Quarters > 0 > cash Flow > cash From Investing
-104000000
Quarters > 0 > cash Flow > cash From Financing
-110000000
Quarters > 0 > cash Flow > net Change In Cash
1137900000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.20696827873114926
Quarters > 0 > ratios > PB
3.0434540154222303
Quarters > 0 > ratios > ROE
3.7427120556704905
Quarters > 0 > ratios > ROA
1.4606576629477392
Quarters > 0 > ratios > FCF
196000000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.052072263549415514
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3839000000
Quarters > 1 > income Statement > cost Of Revenue
1578000000
Quarters > 1 > income Statement > gross Profit
2261000000
Quarters > 1 > income Statement > operating Expenses
1569000000
Quarters > 1 > income Statement > operating Income
692000000
Quarters > 1 > income Statement > interest Expense
107000000
Quarters > 1 > income Statement > pretax Income
588000000
Quarters > 1 > income Statement > net Income
420000000
Quarters > 1 > income Statement > eps
0.21795537104307214
Quarters > 1 > income Statement > dividends Per Share
-393000000
Quarters > 1 > income Statement > shares Outstanding
1927000000
Quarters > 1 > income Statement > income Tax Expense
168000000
Quarters > 1 > income Statement > EBITDA
837000000
Quarters > 1 > income Statement > operating Margin
18.02552748111487
Quarters > 1 > income Statement > total Other Income Expense Net
-104000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1070000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2856000000
Quarters > 1 > balance Sheet > inventories
1776000000
Quarters > 1 > balance Sheet > total Current Assets
5854000000
Quarters > 1 > balance Sheet > property Plant Equipment
2038000000
Quarters > 1 > balance Sheet > total Assets
27132000000
Quarters > 1 > balance Sheet > payables
2568000000
Quarters > 1 > balance Sheet > short Term Debt
1591000000
Quarters > 1 > balance Sheet > long Term Debt
7057000000
Quarters > 1 > balance Sheet > total Liabilities
16402000000
Quarters > 1 > balance Sheet > equity
10730000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
420000000
Quarters > 1 > cash Flow > depreciation
142000000
Quarters > 1 > cash Flow > change In Working Capital
19000000
Quarters > 1 > cash Flow > cash From Operations
621000000
Quarters > 1 > cash Flow > capital Expenditures
88000000
Quarters > 1 > cash Flow > cash From Investing
-90000000
Quarters > 1 > cash Flow > cash From Financing
-548000000
Quarters > 1 > cash Flow > net Change In Cash
-1055900000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.21795537104307214
Quarters > 1 > ratios > PB
3.0224986020503257
Quarters > 1 > ratios > ROE
3.91425908667288
Quarters > 1 > ratios > ROA
1.5479876160990713
Quarters > 1 > ratios > FCF
533000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.13883823912477208
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3741000000
Quarters > 2 > income Statement > cost Of Revenue
1573000000
Quarters > 2 > income Statement > gross Profit
2168000000
Quarters > 2 > income Statement > operating Expenses
1610000000
Quarters > 2 > income Statement > operating Income
558000000
Quarters > 2 > income Statement > interest Expense
107000000
Quarters > 2 > income Statement > pretax Income
458000000
Quarters > 2 > income Statement > net Income
322000000
Quarters > 2 > income Statement > eps
0.16727272727272727
Quarters > 2 > income Statement > dividends Per Share
-392000000
Quarters > 2 > income Statement > shares Outstanding
1925000000
Quarters > 2 > income Statement > income Tax Expense
136000000
Quarters > 2 > income Statement > EBITDA
701000000
Quarters > 2 > income Statement > operating Margin
14.91579791499599
Quarters > 2 > income Statement > total Other Income Expense Net
-100000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1057000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2817000000
Quarters > 2 > balance Sheet > inventories
1680000000
Quarters > 2 > balance Sheet > total Current Assets
5710000000
Quarters > 2 > balance Sheet > property Plant Equipment
1927000000
Quarters > 2 > balance Sheet > total Assets
26257000000
Quarters > 2 > balance Sheet > payables
2332000000
Quarters > 2 > balance Sheet > short Term Debt
2468000000
Quarters > 2 > balance Sheet > long Term Debt
6196750000
Quarters > 2 > balance Sheet > total Liabilities
16204000000
Quarters > 2 > balance Sheet > equity
10053000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
322000000
Quarters > 2 > cash Flow > depreciation
136000000
Quarters > 2 > cash Flow > change In Working Capital
-77000000
Quarters > 2 > cash Flow > cash From Operations
428000000
Quarters > 2 > cash Flow > capital Expenditures
179000000
Quarters > 2 > cash Flow > cash From Investing
-167000000
Quarters > 2 > cash Flow > cash From Financing
-310000000
Quarters > 2 > cash Flow > net Change In Cash
-13000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.16727272727272727
Quarters > 2 > ratios > PB
3.222694717994628
Quarters > 2 > ratios > ROE
3.2030239729434
Quarters > 2 > ratios > ROA
1.2263396427619302
Quarters > 2 > ratios > FCF
249000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.06655974338412189
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3662000000
Quarters > 3 > income Statement > cost Of Revenue
1592000000
Quarters > 3 > income Statement > gross Profit
2070000000
Quarters > 3 > income Statement > operating Expenses
1587000000
Quarters > 3 > income Statement > operating Income
483000000
Quarters > 3 > income Statement > interest Expense
148000000
Quarters > 3 > income Statement > pretax Income
346000000
Quarters > 3 > income Statement > net Income
293000000
Quarters > 3 > income Statement > eps
0.1518921721099015
Quarters > 3 > income Statement > dividends Per Share
-393000000
Quarters > 3 > income Statement > shares Outstanding
1929000000
Quarters > 3 > income Statement > income Tax Expense
53000000
Quarters > 3 > income Statement > EBITDA
644000000
Quarters > 3 > income Statement > operating Margin
13.189513926815948
Quarters > 3 > income Statement > total Other Income Expense Net
-137000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1070000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2659000000
Quarters > 3 > balance Sheet > inventories
1591000000
Quarters > 3 > balance Sheet > total Current Assets
5525000000
Quarters > 3 > balance Sheet > property Plant Equipment
1849000000
Quarters > 3 > balance Sheet > total Assets
25601000000
Quarters > 3 > balance Sheet > payables
2254000000
Quarters > 3 > balance Sheet > short Term Debt
1588000000
Quarters > 3 > balance Sheet > long Term Debt
6942000000
Quarters > 3 > balance Sheet > total Liabilities
15933000000
Quarters > 3 > balance Sheet > equity
9668000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
293000000
Quarters > 3 > cash Flow > depreciation
148000000
Quarters > 3 > cash Flow > change In Working Capital
262000000
Quarters > 3 > cash Flow > cash From Operations
793000000
Quarters > 3 > cash Flow > capital Expenditures
132000000
Quarters > 3 > cash Flow > cash From Investing
-132000000
Quarters > 3 > cash Flow > cash From Financing
-587000000
Quarters > 3 > cash Flow > net Change In Cash
13000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.1518921721099015
Quarters > 3 > ratios > PB
3.3579923458833263
Quarters > 3 > ratios > ROE
3.0306164666942492
Quarters > 3 > ratios > ROA
1.1444865434943947
Quarters > 3 > ratios > FCF
661000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.1805024576734025
Quarters > 3 > health Score
56
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
15455000000
Annuals > 0 > income Statement > cost Of Revenue
6496000000
Annuals > 0 > income Statement > gross Profit
8959000000
Annuals > 0 > income Statement > operating Expenses
7118000000
Annuals > 0 > income Statement > operating Income
1841000000
Annuals > 0 > income Statement > interest Expense
431000000
Annuals > 0 > income Statement > pretax Income
1415000000
Annuals > 0 > income Statement > net Income
1030000000
Annuals > 0 > income Statement > eps
0.5356214248569943
Annuals > 0 > income Statement > dividends Per Share
-1552000000
Annuals > 0 > income Statement > shares Outstanding
1923000000
Annuals > 0 > income Statement > income Tax Expense
385000000
Annuals > 0 > income Statement > EBITDA
2468000000
Annuals > 0 > income Statement > operating Margin
11.912002588159172
Annuals > 0 > income Statement > total Other Income Expense Net
-426000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1070000000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2659000000
Annuals > 0 > balance Sheet > inventories
1591000000
Annuals > 0 > balance Sheet > total Current Assets
5525000000
Annuals > 0 > balance Sheet > property Plant Equipment
1849000000
Annuals > 0 > balance Sheet > total Assets
25601000000
Annuals > 0 > balance Sheet > payables
2254000000
Annuals > 0 > balance Sheet > short Term Debt
1588000000
Annuals > 0 > balance Sheet > long Term Debt
6942000000
Annuals > 0 > balance Sheet > total Liabilities
15933000000
Annuals > 0 > balance Sheet > equity
9668000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
1030000000
Annuals > 0 > cash Flow > depreciation
622000000
Annuals > 0 > cash Flow > change In Working Capital
-571000000
Annuals > 0 > cash Flow > cash From Operations
1769000000
Annuals > 0 > cash Flow > capital Expenditures
434000000
Annuals > 0 > cash Flow > cash From Investing
-425000000
Annuals > 0 > cash Flow > cash From Financing
-1565000000
Annuals > 0 > cash Flow > net Change In Cash
-312000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.5356214248569943
Annuals > 0 > ratios > PB
3.4450103434009103
Annuals > 0 > ratios > ROE
10.653702937525859
Annuals > 0 > ratios > ROA
4.023280340611695
Annuals > 0 > ratios > FCF
1335000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.08637981235846004
Annuals > 0 > health Score
55
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
15444000000
Annuals > 1 > income Statement > cost Of Revenue
6801000000
Annuals > 1 > income Statement > gross Profit
8643000000
Annuals > 1 > income Statement > operating Expenses
6131000000
Annuals > 1 > income Statement > operating Income
2512000000
Annuals > 1 > income Statement > interest Expense
358000000
Annuals > 1 > income Statement > pretax Income
2190000000
Annuals > 1 > income Statement > net Income
1664000000
Annuals > 1 > income Statement > eps
0.8689036196632945
Annuals > 1 > income Statement > dividends Per Share
-14554000000
Annuals > 1 > income Statement > shares Outstanding
1915057047
Annuals > 1 > income Statement > income Tax Expense
526000000
Annuals > 1 > income Statement > EBITDA
3175000000
Annuals > 1 > income Statement > operating Margin
16.265216265216264
Annuals > 1 > income Statement > total Other Income Expense Net
-322000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1382000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2640000000
Annuals > 1 > balance Sheet > inventories
1851000000
Annuals > 1 > balance Sheet > total Current Assets
6138000000
Annuals > 1 > balance Sheet > property Plant Equipment
2042000000
Annuals > 1 > balance Sheet > total Assets
27851000000
Annuals > 1 > balance Sheet > payables
2489000000
Annuals > 1 > balance Sheet > short Term Debt
643000000
Annuals > 1 > balance Sheet > long Term Debt
7687000000
Annuals > 1 > balance Sheet > total Liabilities
16640000000
Annuals > 1 > balance Sheet > equity
11211000000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1664000000
Annuals > 1 > cash Flow > depreciation
627000000
Annuals > 1 > cash Flow > change In Working Capital
797000000
Annuals > 1 > cash Flow > cash From Operations
3168000000
Annuals > 1 > cash Flow > capital Expenditures
469000000
Annuals > 1 > cash Flow > cash From Investing
-488000000
Annuals > 1 > cash Flow > cash From Financing
-2527000000
Annuals > 1 > cash Flow > net Change In Cash
151000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.8689036196632945
Annuals > 1 > ratios > PB
2.9585931722451164
Annuals > 1 > ratios > ROE
14.842565337614843
Annuals > 1 > ratios > ROA
5.974650820437327
Annuals > 1 > ratios > FCF
2699000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.17476042476042475
Annuals > 1 > health Score
74
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
14950000000
Annuals > 2 > income Statement > cost Of Revenue
6665000000
Annuals > 2 > income Statement > gross Profit
8285000000
Annuals > 2 > income Statement > operating Expenses
5610000000
Annuals > 2 > income Statement > operating Income
2675000000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
2637000000
Annuals > 2 > income Statement > net Income
2064000000
Annuals > 2 > income Statement > eps
1.0778664510933764
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
1914894000
Annuals > 2 > income Statement > income Tax Expense
573000000
Annuals > 2 > income Statement > EBITDA
3281000000
Annuals > 2 > income Statement > operating Margin
17.892976588628763
Annuals > 2 > income Statement > total Other Income Expense Net
-38000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1231000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2297000000
Annuals > 2 > balance Sheet > inventories
2226000000
Annuals > 2 > balance Sheet > total Current Assets
5877000000
Annuals > 2 > balance Sheet > property Plant Equipment
1820000000
Annuals > 2 > balance Sheet > total Assets
27316000000
Annuals > 2 > balance Sheet > payables
1829000000
Annuals > 2 > balance Sheet > short Term Debt
35000000
Annuals > 2 > balance Sheet > long Term Debt
8930000000
Annuals > 2 > balance Sheet > total Liabilities
7346000000
Annuals > 2 > balance Sheet > equity
19970000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
2087000000
Annuals > 2 > cash Flow > depreciation
644000000
Annuals > 2 > cash Flow > change In Working Capital
-513000000
Annuals > 2 > cash Flow > cash From Operations
2525000000
Annuals > 2 > cash Flow > capital Expenditures
375000000
Annuals > 2 > cash Flow > cash From Investing
-390000000
Annuals > 2 > cash Flow > cash From Financing
-1583000000
Annuals > 2 > cash Flow > net Change In Cash
491000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
1.0778664510933764
Annuals > 2 > ratios > PB
1.6607893880821232
Annuals > 2 > ratios > ROE
10.335503254882324
Annuals > 2 > ratios > ROA
7.55601112900864
Annuals > 2 > ratios > FCF
2150000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.14381270903010032
Annuals > 2 > health Score
79
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
15054000000
Annuals > 3 > income Statement > cost Of Revenue
6635000000
Annuals > 3 > income Statement > gross Profit
8419000000
Annuals > 3 > income Statement > operating Expenses
5499000000
Annuals > 3 > income Statement > operating Income
2920000000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
2925000000
Annuals > 3 > income Statement > net Income
2078000000
Annuals > 3 > income Statement > eps
1.1000686616484194
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
1888973000
Annuals > 3 > income Statement > income Tax Expense
847000000
Annuals > 3 > income Statement > EBITDA
3656000000
Annuals > 3 > income Statement > operating Margin
19.39683804968779
Annuals > 3 > income Statement > total Other Income Expense Net
5000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
740000000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2331000000
Annuals > 3 > balance Sheet > inventories
1702000000
Annuals > 3 > balance Sheet > total Current Assets
4927000000
Annuals > 3 > balance Sheet > property Plant Equipment
1827000000
Annuals > 3 > balance Sheet > total Assets
27929000000
Annuals > 3 > balance Sheet > payables
1827000000
Annuals > 3 > balance Sheet > short Term Debt
47000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7530000000
Annuals > 3 > balance Sheet > equity
20399000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
2031000000
Annuals > 3 > cash Flow > depreciation
731000000
Annuals > 3 > cash Flow > change In Working Capital
-3132000000
Annuals > 3 > cash Flow > cash From Operations
334000000
Annuals > 3 > cash Flow > capital Expenditures
295000000
Annuals > 3 > cash Flow > cash From Investing
-171000000
Annuals > 3 > cash Flow > cash From Financing
-1583000000
Annuals > 3 > cash Flow > net Change In Cash
122000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.1000686616484194
Annuals > 3 > ratios > PB
1.6038537359674494
Annuals > 3 > ratios > ROE
10.186773861463799
Annuals > 3 > ratios > ROA
7.440295033835797
Annuals > 3 > ratios > FCF
39000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.0025906735751295338
Annuals > 3 > health Score
65
Valuation > metrics > PE
23.0933
Valuation > metrics > PB
3.0434540154222303
Valuation > final Score
79.5654598457777
Valuation > verdict
0.7% Overvalued
Profitability > metrics > ROE
3.7427120556704905
Profitability > metrics > ROA
6.598143236074271
Profitability > metrics > Net Margin
0.10573857598299681
Profitability > final Score
43
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5623471882640587
Risk > metrics > Interest Coverage
6.763440860215054
Risk > final Score
57
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.3853927423059256
Liquidity > metrics > Quick Ratio
0.9733578318787321
Liquidity > final Score
83
Liquidity > verdict
Great
Prev Valuations > 0
69.77501397949675
Prev Valuations > 1
67.77305282005372
Prev Valuations > 2
66.42007654116674
Prev Profitabilities > 0
46
Prev Profitabilities > 1
36
Prev Profitabilities > 2
34
Prev Risks > 0
56
Prev Risks > 1
51
Prev Risks > 2
43
Prev Liquidities > 0
84
Prev Liquidities > 1
72
Prev Liquidities > 2
86
Updated At
2026-01-20T22:07:06.031Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.23
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.21
Earnings History > 1 > eps Estimate
0.22
Earnings History > 1 > eps Difference
-0.01
Earnings History > 1 > surprise Percent
-4.5455
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.22
Earnings History > 2 > eps Estimate
0.24
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-8.3333
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.24
Earnings History > 3 > eps Estimate
0.23
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
4.3478
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-06
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.15
Earnings History > 4 > eps Estimate
0.2
Earnings History > 4 > eps Difference
-0.05
Earnings History > 4 > surprise Percent
-25
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.28
Earnings History > 5 > eps Estimate
0.27
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
3.7037
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.32
Earnings History > 6 > eps Estimate
0.28
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
14.2857
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.28
Earnings History > 7 > eps Estimate
0.25
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
12
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-08
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.31
Earnings History > 8 > eps Estimate
0.28
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
10.7143
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-10-26
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.31
Earnings History > 9 > eps Estimate
0.31
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-20
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.32
Earnings History > 10 > eps Estimate
0.3
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
6.6667
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-02
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.19
Earnings History > 11 > eps Estimate
0.32
Earnings History > 11 > eps Difference
-0.13
Earnings History > 11 > surprise Percent
-40.625
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-01-04
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.91
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.91
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.22
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.22
Earnings History > 13 > surprise Percent
-
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AKenvue stock price slips as Kimberly-Clark drops, deal vote stays in focus TechStock²
Read more →Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix - TechStock²
1/21/2026
Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix TechStock²
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$19.3333
Analyst Picks
Strong Buy
3
Buy
2
Hold
14
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Kenvue Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.23
Date
2025-09-30
EPS Actual
0.21
EPS Estimate
0.22
EPS Difference
-0.01
Surprise Percent
-4.5455%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.